Delivery of RNA interference

被引:162
|
作者
Li, Charles X. [1 ]
Parker, Amy [1 ]
Menocal, Ellen [1 ]
Xiang, Shuanglin [1 ]
Borodyansky, Laura [1 ]
Fruehauf, Johannes H. [1 ]
机构
[1] Harvard Univ, Sch Med, Div Gastroenterol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
关键词
RNA interference; gene therapy; gene delivery; therapeutic RNAi; transkingdom RNA interference;
D O I
10.4161/cc.5.18.3192
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Over the last few years, RNA Interference (RNAi), a naturally occurring mechanism of gene regulation conserved in plant and mammalian cells, has opened numerous novel opportunities for basic research across the field of biology. While RNAi has helped accelerate discovery and understanding of gene functions, it also has great potential as a therapeutic and potentially prophylactic modality. Challenging diseases failing conventional therapeutics could become treatable by specific silencing of key pathogenic genes. More specifically, therapeutic targets previously deemed "undruggable" by small molecules, are now coming within reach of RNAi based therapy. For RNAi to be effective and elicit gene silencing response, the double-stranded RNA molecules must be delivered to the target cell. Unfortunately, delivery of these RNA duplexes has been challenging, halting rapid development of RNAi-based therapies. In this review we present current advancements in the field of siRNA delivery methods, including the pros and cons of each method.
引用
收藏
页码:2103 / 2109
页数:7
相关论文
共 50 条
  • [11] Exosomes: Nanoparticulate tools for RNA interference and drug delivery
    Shahabipour, Fahimeh
    Barati, Nastaran
    Johnston, Thomas P.
    Derosa, Giuseppe
    Maffioli, Pamela
    Sahebkar, Amirhossein
    JOURNAL OF CELLULAR PHYSIOLOGY, 2017, 232 (07) : 1660 - 1668
  • [12] RNA interference induced by the cationic lipid delivery of siRNA
    Bouxsein, NF
    McAllister, CS
    Ewert, K
    Samuel, CE
    Safinya, CR
    BIOPHYSICAL JOURNAL, 2005, 88 (01) : 420A - 420A
  • [13] Polyethylenimine and chitosan carriers for the delivery of RNA interference effectors
    Molinaro, Roberto
    Wolfram, Joy
    Federico, Cinzia
    Cilurzo, Felisa
    Di Marzio, Luisa
    Ventura, Cinzia A.
    Carafa, Maria
    Celia, Christian
    Fresta, Massimo
    EXPERT OPINION ON DRUG DELIVERY, 2013, 10 (12) : 1653 - 1668
  • [14] Delivery strategies: RNA interference in agriculture and human health
    Heidebrecht, Richard W., Jr.
    PEST MANAGEMENT SCIENCE, 2017, 73 (04) : 686 - 691
  • [15] Proof of RNA Interference in Humans after Systemic Delivery of siRNAs
    Kurreck, Jens
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2010, 49 (36) : 6258 - 6259
  • [16] RNA interference in immune cells by use of osmotic delivery of siRNA
    Aoki, M
    Ishii, T
    Kanaoka, M
    Kimura, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 341 (02) : 326 - 333
  • [17] Systemic Delivery of Targeted RNA Interference as a Treatment for Myotonic Dystrophy
    Chamberlain, Joel R.
    Stepniak, Eva
    NEUROLOGY, 2011, 76 (09) : A452 - A452
  • [18] RNA interference by nanofiber-based siRNA delivery system
    Cao, Haoqing
    Jiang, Xu
    Chai, Chou
    Chew, Sing Yian
    JOURNAL OF CONTROLLED RELEASE, 2010, 144 (02) : 203 - 212
  • [19] RNA interference-based therapy and its delivery systems
    Chen, Xiuhui
    Mangala, Lingegowda S.
    Rodriguez-Aguayo, Cristian
    Kong, Xianchao
    Lopez-Berestein, Gabriel
    Sood, Anil K.
    CANCER AND METASTASIS REVIEWS, 2018, 37 (01) : 107 - 124
  • [20] Impact of delivery systems on siRNA immune activation and RNA interference
    Forsbach, Alexandra
    Mueller, Christian
    Montino, Carmen
    Kritzler, Andrea
    Curdt, Rainer
    Benahmed, Amina
    Jurk, Marion
    Vollmer, Joerg
    IMMUNOLOGY LETTERS, 2012, 141 (02) : 169 - 180